BackOncopeptides AB (publ) Overview

Oncopeptides AB (publ) Total Liabilities

Latest total liabilities for ONPPF: $180M.

Get informed when a big investor buys or sells

+ Follow
Total Liabilities
$179.25M
↓ 13.87% YoYΔ $-28.87M vs prior year quarter

Peer trimmed avg / median

Loading

Oncopeptides AB (publ) Total Liabilities History

Loading

Oncopeptides AB (publ) vs. peers: Total Liabilities Comparison

Loading

Oncopeptides AB (publ) Total Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Oncopeptides AB (publ) (ONPPF) FAQ

As of the most recent data (March 2025), ONPPF shows a total liabilities of $180M. That compares with $210M in the prior-year period — down 13.9% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, ONPPF's total liabilities is now $180M (was $210M) — a 13.9% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Oncopeptides AB (publ) is outperforming or lagging.

Tracking ONPPF's total liabilities over time shows whether Oncopeptides AB (publ) is scaling, shrinking, or reshaping that part of the business. The current reading is $180M That compares with $210M in the prior-year period — down 13.9% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total liabilities page, Stockcircle has Oncopeptides AB (publ)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total liabilities (currently $180M) with ownership activity and broader fundamentals.

Oncopeptides AB (publ)'s total liabilities is $180M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.